This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Lamotrigine and blood dyscrasias

Authoring team

  • various blood dyscrasias have been reported associated with the use of lamotrigine world-wide

  • assessment of individual reports indicates that lamotrigine is likely to be the causative factor in the reported cases of blood dyscrasias associated with use of lamotrigine

  • routine FBC monitoring is not, at present, recommended in patients treated with lamotrigine

Check the summary of product characteristics before prescribing this drug.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.